Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  clarithromycin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: KMU-IRB00003151, VGHKS95-CT3-11, NCT00656968
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 2004.00, NCI-2009-01543, FHCRC-2004.00, 6004, MEDIMMUNE-FHCRC-2004.00, NCT00217438
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CPPDM95-084, P30CA016672, MDA-CPPDM-95084, NCI-T95-0003D, CDR0000064361, T95-0003, NCT00002682
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-20961, CRC-EORTC-20961, HOVON-33, NCT00003151
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068084, P30CA015083, 979202, MAYO-979202, NCI-P00-0163, NCT00006219
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0409007427, NCT00151203
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-038, NCT00461084
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 1767.00, NCI-2011-00387, FHCRC-1767.00, 5589, CELGENE-FHCRC-1767.00, NCT00182663
Lenalidomide, Dexamethasone and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant For Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2135.00, NCI-2010-02116, FHCRC-2135.00, 6435, NCT00445692
A Study of LY2835219 in Participants With Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 15173, I3Y-MC-JPBE, NCT02117648
Helicobacter Pylori Eradication to Prevent Gastric Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 30 to 59
Sponsor: Other
Protocol IDs: SMMU20100501, NCT01133951
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Phase: No phase specified
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: PRT10T, NCT01264822
Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D961HC00011, NCT01435525
Start Over